Funding Rounds
ApoGlyx

ApoGlyx Unknown (2021, $0M)

ApoGlyx

A virtual biotech company focused on developing oral therapy for type 2 diabetes patients in the pre-clinical stage.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $0.70M

Raised Date: 2021-01-01

Investors